Tesamorelin / Ipamorelin
Two growth-hormone peptides in one vial · From $99
Overview
A two-component vial pairing the trans-3-hexenoylated GHRH(1-44) analogue with the selective pentapeptide ghrelin-receptor agonist, at 10 mg and 5 mg. The hexenoyl modification confers resistance to DPP-4 cleavage relative to unmodified GHRH, and the pair is used in pituitary-cell work examining the two secretagogue receptor systems together. Purity is reported per component on the certificate.
- Purity
- ≥ 99%
- Form
- Lyophilized powder
- Components
- 2, 15 mg total
- Storage
- −20 °C, desiccated, dark
Also known as Tesamorelin + Ipamorelin.
Research explained
The research interest
This blend brings together two compounds discussed in hormone-release research.
What was studied
The selected paper measures responses to ipamorelin alone in cells and animals.
Evidence context
The selected source concerns ipamorelin alone in cells and animals, rather than the complete blend.
Selected-source check, not a complete clinical review. No human-use recommendation.
Components
Specifications
Composition
- Tesamorelin
- 10 mg
- Ipamorelin
- 5 mg
- Total peptide
- 15 mg
Material
- Purity, RP-HPLC
- ≥ 99%
- Form
- Lyophilized powder
- Appearance
- White to off-white lyophilized powder
- Vial sizes
- 15 mg
Handling
- Solubility
- Soluble in water and aqueous buffers. Laboratory solvent compatibility only.
- Storage
- Lyophilized powder stored at -20 °C, desiccated and protected from light; long-term storage at -80 °C. Avoid repeated freeze-thaw cycles of stock solutions.
Literature and research use
Literature is cited on each component's own listing.
Citations describe published preclinical and in-vitro findings for this compound class and are not a representation about this material.
Research use only
All products listed on this site are supplied strictly as chemical reference materials for in-vitro laboratory research and are labelled For Research Use Only. They are not drugs, foods, cosmetics, or medical devices. They are not intended to diagnose, treat, cure, or prevent any condition, and are not for human or veterinary consumption or administration under any circumstances.
Research use policy ›